Compugen Ltd. Ordinary Shares (CGEN)
Stock · NASDAQ · Health Care
$2.6as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$2.01
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $217.54M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
Compugen Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- CGENCompugen Ltd. Ordinary Shares$2.6▼ 5.80%Market cap $217.54MP/E —
- TARAProtara Therapeutics Inc. Common Stock$3.82▼ 4.26%Market cap $230.44MP/E —$3.02$7.82
- VYGRVoyager Therapeutics Inc. Common Stock$3.54▲ 2.17%Market cap $189.12MP/E —$2.94$5.55
- SRZNSurrozen Inc. Common Stock$22.42▼ 6.62%Market cap $251.25MP/E —$10.73$35
- ARMPArmata Pharmaceuticals Inc. Common Stock$5.24▼ 3.50%Market cap $172.54MP/E —$2.4$16.34
- ABOSAcumen Pharmaceuticals Inc. Common Stock$2.92▼ 3.63%Market cap $164.68MP/E —$1.21$3.6
- LENZLENZ Therapeutics Inc. Common Stock$5.12▲ 6.34%Market cap $163.67MP/E —$4.54$50.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CGEN Compugen Ltd. Ordinary Shares | $217.54M | — | $2.6 | ▼ 5.80% | |
| TARA Protara Therapeutics Inc. Common Stock | $230.44M | — | $3.82 | ▼ 4.26% | $3.02$7.82 |
| VYGR Voyager Therapeutics Inc. Common Stock | $189.12M | — | $3.54 | ▲ 2.17% | $2.94$5.55 |
| SRZN Surrozen Inc. Common Stock | $251.25M | — | $22.42 | ▼ 6.62% | $10.73$35 |
| ARMP Armata Pharmaceuticals Inc. Common Stock | $172.54M | — | $5.24 | ▼ 3.50% | $2.4$16.34 |
| ABOS Acumen Pharmaceuticals Inc. Common Stock | $164.68M | — | $2.92 | ▼ 3.63% | $1.21$3.6 |
| LENZ LENZ Therapeutics Inc. Common Stock | $163.67M | — | $5.12 | ▲ 6.34% | $4.54$50.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Compugen: Better Runway Ahead Of MAIASeekingAlpha · 8/6/2026
- Compugen Ltd. (CGEN) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/3/2026
- Compugen Q2 EPS $(0.07), Inline, Sales $2.602M Beat $1.606M EstimateBenzinga · 8/3/2026
Insider Activity
Insider Actions →Acquired
552.0K
Disposed
0
- Zurit Levine · July 29, 2026 · Grant24.0K
- Zurit Levine · July 29, 2026 · Grant18.0K
- David Silberman · July 29, 2026 · Grant26.0K
- David Silberman · July 29, 2026 · Grant19.5K
- Eran Ophir · July 29, 2026 · Grant200.0K
- Cohen-Dayag Anat · July 29, 2026 · Grant100.0K
- Eran Perry · July 29, 2026 · Grant10.0K
- Eran Perry · July 29, 2026 · Grant7.5K
- Ferre Pierre · July 29, 2026 · Grant70.0K
- Russo Sharon Kredo · July 29, 2026 · Grant24.0K
- Russo Sharon Kredo · July 29, 2026 · Grant18.0K
- Savitzky Kinneret Livnat · July 29, 2026 · Grant10.0K
- Savitzky Kinneret Livnat · July 29, 2026 · Grant7.5K
- Mathias Hukkelhoven · July 29, 2026 · Grant10.0K
- Mathias Hukkelhoven · July 29, 2026 · Grant7.5K
See the full, filterable feed with live charts on the MarketWall dashboard.